Abstract:Background Genetic testing serves as a valuable element of reproductive care, applicable at various stages of the reproductive journey: (i) before pregnancy, when a couple's genetic reproductive risk can be evaluated; (ii) before embryo implantation, as part of in vitro fertilization (IVF) treatment, to ascertain several inherited or de novo genetic/chromosomal diseases of the embryo before transfer; (iii) during the prenatal period, to assess the genetic costitution of the fetus. Preconception carrier screening (CS) is a genetic test typically performed on couples planning a pregnancy. The primary purpose of CS is to identify couples at‐risk of conceiving a child affected by a severe genetic disorder with autosomal recessive or X‐linked inheritance. Detection of high reproductive risk through CS allows prospective parents to be informed of their predisposition and improve reproductive decision‐making. These include undergoing IVF with preimplantation genetic testing (PGT) or donor gametes, prenatal diagnosis, adoption, remaining childless, taking no actions. Both the presence of the affected gene (PGT‐M) and chromosomal status (PGT‐A) of the embryo can be comprehensively assessed through modern approaches. Objectives We provide a review of CS and PGT applications to equip healthcare providers with up‐to‐date information regarding their opportunities and complexities. Results and Discussion The use of CS and PGT is currently considered the most effective intervention for avoiding both an affected pregnancy whilst using autologous gametes in couples with known increased risk, and chromosomal abnormalities. As our understanding in the genetic component in pathological conditions increases, the number of tested disorders will expand, offering a more thorough assessment of one's genetic inheritance. Nevertheless, implementation and development in this field must be accompanied by scientific and ethical considerations to ensure this approach serves the best long‐term interests of individuals and society, promoting justice and autonomy and preserving parenthood and the healthcare system. Conclusion The combination of CS and PGT aligns with principles of personalized medicine by offering reproductive care tailored to the individual's genetic makeup.

The impact of genetics on reproductive decisions, such as preimplantation genetic diagnosis.

Research Progress and Challenges of Preimplantation Genetic Testing for Polygenic Diseases.

Application of the High-throughput Technologies in Preimplantation Genetic Diagnosis

Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers.

[Evaluation of the Safety and Reliability of Preimplantation Genetic Diagnosis].

Advances in Preimplantation Genetic Diagnosis/screening

[The Latest Development in Preimplantation Genetic Diagnosis].

Addressing ethical issues related to prenatal diagnostic procedures

[Advance in the Methods of Preimplantation Genetic Diagnosis for Single Gene Diseases].

Influential Factors And Strategies of Preimplantation Genetic Diagnosis Informed Consent

A Novel Preimplantation Genetic Testing Strategy for a Subtelomeric Genetic Disorder: A Case Study

The current clinical applications of preimplantation genetic testing (PGT): acknowledging the limitations of biology and technology

Ethical Consideration of the Preimplantation Genetic Diagnosis

[Principle, Method and Application of Preimplantation Genetic Diagnosis].

Preconception carrier screening and preimplantation genetic testing in the infertility management

Current Status and New Progress of the Preimplantation Genetic Testing

Validity Analysis of Preimplantation Genetic Diagnosis

Application of Preimplantation Genetic Diagnosis in Eugenics

Preimplantation genetic testing in the current era, a review

Noninvasive preimplantation genetic testing in assisted reproductive technology: current state and future perspectives

Recent Advances of Preimplantation Genetic Diagnosis